Organ Preservation Market Size & Growth Report

Organ Preservation Market Overview

The global organ preservation market has witnessed substantial growth driven by the increasing demand for organ transplants worldwide. Organ preservation is essential for maintaining the viability of organs from donors to recipients, and as the global population ages and the need for organ transplants grows, the market continues to expand. Advancements in preservation technologies, such as hypothermic machine perfusion and organ-specific preservation solutions, are also driving market growth. This market is crucial in facilitating better success rates for transplant procedures and improving the quality of life for patients receiving transplants.

Organ Preservation Market Size

The global organ preservation market was valued at USD 281.7 million in 2024 and is projected to grow significantly over the coming decade. As the need for organ transplants rises, especially in regions with aging populations, the market is expected to expand at a compound annual growth rate (CAGR) of 6.62% from 2025 to 2034. By 2034, the market is anticipated to reach a value of approximately USD 500.2 million. This growth is indicative of the increasing importance of organ preservation technologies and techniques in the healthcare industry.

Organ Preservation Market Share

The organ preservation market is segmented based on different preservation methods and types of organs. Key players in the market include companies that offer preservation solutions and technologies for various organs such as the heart, kidney, liver, and lungs. The market share distribution is shaped by advancements in hypothermic preservation, machine perfusion, and perfusion devices for organs like kidneys and livers. Market leaders like OrganOx Limited and Transplant Biomedicals S.L. play pivotal roles in shaping the market's current structure. These companies are collaborating with hospitals, transplant centers, and research institutions to expand their market presence and offerings.

Organ Preservation Market Trends

Several trends are currently shaping the global organ preservation market. One of the most notable trends is the increasing adoption of advanced preservation technologies such as normothermic machine perfusion (NMP) and ex-vivo lung perfusion (EVLP), which improve the quality and longevity of preserved organs. These technologies have seen increasing clinical success and are driving research into expanding their applications to other organ types. Additionally, there is a rising emphasis on personalized preservation solutions tailored to specific organ types, leading to the development of custom preservation solutions that improve outcomes.

Organ Preservation Market Analysis

The organ preservation market is directly linked to the growing number of organ transplant surgeries worldwide. With a focus on ensuring the viability of organs after retrieval, organ preservation plays a crucial role in facilitating successful transplant surgeries. Organ preservation can be broadly divided into static cold storage, machine perfusion, and other advanced technologies. Machine perfusion, especially hypothermic and normothermic perfusion methods, is gaining significant traction due to its ability to prolong organ preservation time and improve post-transplant outcomes. Regulatory bodies and healthcare institutions are recognizing the importance of preserving organs efficiently, which is expected to increase investment in preservation technologies.

One of the major factors driving the market is the increased demand for organ transplants, especially in developed regions with an aging population. The shortage of suitable donor organs has made organ preservation a crucial aspect of maximizing organ availability. The success rates of organ transplants have improved with the advent of advanced preservation technologies, leading to better long-term outcomes for patients. Despite the growing demand, challenges such as donor organ shortages, organ rejection, and the high costs of advanced preservation technologies still persist.

Organ Preservation Market Segmentation

The organ preservation market is segmented into various categories based on preservation methods, organ types, and geographic regions.

By Preservation Method:

Cold Storage: Traditional and widely used method, often applied for kidney and liver preservation.
Machine Perfusion: This includes hypothermic machine perfusion (HMP), normothermic machine perfusion (NMP), and ex-vivo lung perfusion (EVLP).
Other Techniques: Includes novel approaches like chemical and biotechnological preservation.

By Organ Type:

Kidney Preservation: The most commonly preserved organ for transplant due to the high incidence of renal failure.
Liver Preservation: Essential for patients with liver cirrhosis or other end-stage liver diseases.
Heart Preservation: Crucial for patients with severe heart conditions requiring heart transplants.
Lung Preservation: Includes advanced techniques such as ex-vivo lung perfusion (EVLP).

By End User:

Hospitals and Transplant Centers: The largest segment, where most organ preservation and transplantation procedures take place.
Research and Academic Institutions: These institutions are vital for advancing research in organ preservation technologies and solutions.

Organ Preservation Market Growth

The global organ preservation market is experiencing steady growth due to increasing awareness about organ donation and the need for efficient preservation techniques. The demand for organ transplants is surging, and with advancements in preservation methods, more organs are being successfully preserved for longer durations. Technologies like machine perfusion offer significant improvements over traditional methods, contributing to better organ quality, reduced ischemia time, and improved post-transplant outcomes. In addition, advancements in organ preservation are enabling more organs to be viable for transplantation, which is crucial given the global organ shortage.

Recent Developments and Challenges in the Organ Preservation Market

Recent developments in the organ preservation market include innovations in machine perfusion technology. Several key players are focusing on normothermic and hypothermic machine perfusion to maintain organ function at near-normal conditions. Furthermore, there have been advancements in personalized preservation solutions designed to cater to specific organs, ensuring better outcomes after transplantation.

However, challenges still persist, including the high costs of advanced preservation techniques, the limited availability of organ donors, and the risks of organ rejection after transplantation. Moreover, certain organs, such as the heart and lungs, require more complex preservation technologies, which continue to present challenges in ensuring successful transplantation. There is also ongoing research into the use of stem cells and biotechnologies to extend organ viability.

Get a Free Sample Report with a Table of Contents

Key Players

Bridge to Life Limited: Known for their pioneering work in organ preservation, particularly in the development of solutions for liver and kidney preservation.

Avionord SRL: A key player in offering biopreservation solutions for organ transport and preservation.

Carnamedica S.P.: Specializes in preserving hearts and other organs using advanced perfusion techniques.

Dr. Franz Köhler Chemie GmbH: Offers organ preservation solutions with a focus on enhancing organ survival during transport.

Shanghai Genext Medical Technology Co., Ltd.: A company focusing on the development of innovative organ preservation systems.

Transplant Biomedicals S.L.: Known for their efforts to enhance organ viability post-extraction using novel preservation technologies.

Global Transplant Solutions Inc.: A market leader in the development of custom organ preservation solutions tailored to different organ types.

OrganOx Limited: A leader in the development of innovative systems for liver preservation, including normothermic machine perfusion.

Organ Recovery Systems Inc.: Provides advanced preservation technologies, particularly for kidney and lung transplantation.

Institut Georges Lopez, SAS: A company that develops and markets preservation solutions to enhance the viability of organs for transplant.

The organ preservation market is poised for growth as new technologies continue to emerge, offering greater success rates for organ transplants. The combined efforts of healthcare institutions, researchers, and key market players will drive the future of organ preservation, ensuring more lives are saved through successful transplant procedures.